Select your Region     
The Year in Heart Failure Volume 1

Price: £59.99
· Evaluation and critical appraisal of the full range of published literature in the field · Key papers for practice identified and summarised · Single user-friendly volume · Draws on the experience of leading experts in the field
Edited by:
IL Piña, University Hospitals of Cleveland/Case Western Reserve University, Cleveland, Ohio, USA; S Goldstein, Henry Ford Hospital, Detroit, USA; M Dunlap, Veterans Affairs Medical Center, Cleveland, USA.
This has been an important year for the study of heart failure with advances being made on a number of fronts: in pharmacological therapy, surgery and the use of mechanical devices. In addition, we are now in a position to evaluate properly the results of a number of major trials and in this volume the editor presents a critical analysis of these findings. Included here are discussions of nine recent studies including the CHARM, EPHESUS, LIDO and OVERTURE trials, the latest studies of beta-blockers (COMET and CAPRICORN), TNF alpha-inhibitors (ATTACH) and endothelin antagonists (RITZ-4). Also reviewed are the recent studies of devices used in resynchronization therapy (MIRACLE and COMPANION), cardiac splints (ACORN) and also surgical procedures such as CABG (the STITCH trial). This new addition to the ‘Year in’ series is one of the most comprehensive reviews of clinical research dedicated to heart failure currently available.
Cardiologists ▪ General physicians ▪ Doctors in training

Book Details:
978 1 904392 38 5
400pp; 234 x 156mm; Illustrations; Hardback;
Publication Date: January 2005

Privacy Policy | Terms and Conditions of Sale